The Role of Government Reimbursement in Drug Shortages
NBER Working Paper No. 17987
---- Acknowledgements ----
Previously circulated as "Medicare Reimbursements and Shortages of Sterile Injectable Pharmaceuticals." We thank Lanier Benkard, Ernst Berndt, John Beshears, Tim Bresnahan, Jeffrey Clemens, Liran Einav, Sherry Glied, Joshua Gottlieb, Gino Grampp, Mireille Jacobsen, Daniel Kessler, Michael Link, Michael Malecki, Steve Mayer, Jeff Moe, Ted Okon, Mar Reguant, Peter Reiss, Fiona Scott Morton, Jesse Shapiro, Robert Wilson, and Stefanos Zenios for comments. Ridley received research support from Amgen. Yurukoglu and Liebman have no financial interests that relate to this research. Amgen provided the IMS Health data and Erin Fox provided the shortage data. The views expressed herein are those of the author and do not necessarily reflect the views of the National Bureau of Economic Research.